| Ident. | Authors (with country if any) | Title |
|---|
| 001406 |
Robert Jech [République tchèque] ; Jin Klempir [République tchèque] ; Josef Vymazal [République tchèque] ; Jana Zidovska [République tchèque] ; Olga Klempirova [République tchèque] ; Evzen Ruzicka [République tchèque] ; Jan Roth [République tchèque] | Variation of selective gray and white matter atrophy in huntington's disease |
| 001450 |
Mark Mühlau [Allemagne] ; Christian Gaser [Allemagne] ; Afra M. Wohlschl Ger [Allemagne] ; Adolf Weindl [Allemagne] ; Michael St Dtler [Allemagne] ; Michael Valet [Allemagne] ; Claus Zimmer [Allemagne] ; Jan Kassubek [Allemagne] ; Alexander Peinemann [Allemagne] | Striatal gray matter loss in Huntington's disease is leftward biased |
| 001468 |
Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis] | Short-term effects of tetrabenazine on chorea associated with Huntington's disease |
| 001573 |
Christoph M. Kosinski [Allemagne] ; Christiane Schlangen [Allemagne] ; Frank N. Gellerich [Allemagne] ; Zemfira Gizatullina [Allemagne] ; Markus Deschauer [Allemagne] ; Johannes Schiefer [Allemagne] ; Anne B. Young [États-Unis] ; Georg Bernhard Landwehrmeyer [Allemagne] ; Klaus V. Toyka [Allemagne] ; Bernd Sellhaus [Allemagne] ; Katrin S. Lindenberg [États-Unis, Allemagne] | Myopathy as a first symptom of huntington's disease in a marathon runner |
| 001593 |
Karin Van Der Hiele [Pays-Bas] ; Caroline K. Jurgens [Pays-Bas] ; Alla A. Vein [Pays-Bas] ; Robert H. A. M. Reijntjes [Pays-Bas] ; Marie-Noëlle W. Witjes-Ane [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas] ; Gert Van Dijk [Pays-Bas] ; Huub A. M. Middelkoop [Pays-Bas] | Memory activation reveals abnormal EEG in preclinical Huntington's disease |
| 001645 |
Penny E. Greenstein [États-Unis] ; Jean-Paul G. Vonsattel [États-Unis] ; Russell L. Margolis [États-Unis] ; Jeffrey T. Joseph [États-Unis] | Huntington's disease like-2 neuropathology |
| 001660 |
Andrew Feigin [États-Unis] ; David Eidelberg [États-Unis] | Gene transfer therapy for neurodegenerative disorders |
| 001744 |
Christopher Turner [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Anthony H. V. Schapira [Royaume-Uni] | Clinical correlates of mitochondrial function in huntington's disease muscle |
| 001776 |
Christopher Kenney [États-Unis] ; Suzanne Powell [États-Unis] ; Joseph Jankovic [États-Unis] | Autopsy-proven Huntington's disease with 29 trinucleotide repeats |
| 001988 |
Theresa A. Zesiewicz [États-Unis] ; Kelly L. Sullivan [États-Unis] ; Robert A. Hauser [États-Unis] ; Juan Sanchez-Ramos [États-Unis] | Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease |
| 001A68 |
Aileen K. Ho [Royaume-Uni] ; Anna O. G. Robbins [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Huntington's disease patients have selective problems with insight |
| 001B13 |
Jean-Pascal Lefaucheur [France] ; Isabelle Menard-Lefaucheur [France] ; Patrick Maison [France] ; Sophie Baudic [France] ; Pierre Cesaro [France] ; Marc Peschanski [France] ; Anne-Catherine Bachoud-Levi [France] | Electrophysiological deterioration over time in patients with huntington's disease |
| 001B46 |
Klaus Seppi [Autriche] ; Michael F. H. Schocke [Autriche] ; Katherina J. Mair [Autriche] ; Regina Esterhammer [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Barbara Utermann [Autriche] ; Karl Egger [Autriche] ; Christian Brenneis [Autriche] ; Roberta Granata [Autriche] ; Sylvia Boesch [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Diffusion-weighted imaging in Huntington's disease |
| 001B47 |
H. Diana Rosas [États-Unis] ; David S. Tuch [États-Unis] ; Nathanael D. Hevelone [États-Unis] ; Alexandra K. Zaleta [États-Unis] ; Mark Vangel [États-Unis] ; Steven M. Hersch [États-Unis] ; David H. Salat [États-Unis] | Diffusion tensor imaging in presymptomatic and early huntington's disease : Selective white matter pathology and its relationship to clinical measures |
| 001C00 |
Richard Dubinsky [États-Unis] ; Carolyn Gray [États-Unis] | CYTE-I-HD : Phase I dose finding and tolerability study of cysteamine (cystagon) in huntington's disease |
| 001C32 |
Carsten Saft [Allemagne] ; Jürgen Andrich [Allemagne] ; Nina-Marie Meisel [Allemagne] ; Horst Przuntek [Allemagne] ; Thomas Müller [Allemagne] | Assessment of simple movements reflects impairment in Huntington's disease |
| 001D29 |
Ashwini K. Rao [États-Unis] ; Lori Quinn [États-Unis] ; Karen S. Marder [États-Unis] | Reliability of spatiotemporal gait outcome measures in Huntington's disease |
| 001D81 |
Richard M. Dubinsky [États-Unis] | No going home for hospitalized Huntington's disease patients |
| 001D95 |
Carsten Saft [Allemagne] ; Jochen Zange [Allemagne] ; Jiirgen Andrich [Allemagne] ; Klaus Müller [Allemagne] ; Katrin Lindenberg [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Matthias Vorgerd [Allemagne] ; Peter H. Kraus [Allemagne] ; Horst Przuntek [Allemagne] ; Ludger Schols [Allemagne] | Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease |
| 001E34 |
Jeffrey J. Sevigny [États-Unis] ; Steven S. M. Chin [États-Unis] ; Yvonne Milewski [États-Unis] ; Mark W. Albers [États-Unis] ; Marc L. Gordon [États-Unis] ; Karen Marder [États-Unis] | HIV encephalitis simulating Huntington's disease |
| 001E54 |
Belinda Bilney [Australie] ; Meg E. Morris [Australie] ; Andrew Churchyard [Australie] ; Edmond Chiu [Australie] ; Nellie Georgiou-Karistianis [Australie] | Evidence for a disorder of locomotor timing in Huntington's disease |
| 001F12 |
Spiridon Papapetropoulos [États-Unis] ; Roberto Lopez-Alberola [États-Unis] ; Lisa Baumbach [États-Unis] ; Angela Russell [États-Unis] ; Manuel A. Gonzalez [États-Unis] ; Brian C. Bowen [États-Unis] ; Carlos Singer [États-Unis] | Case of maternally transmitted juvenile Huntington's disease with a very large trinucleotide repeat |
| 001F63 |
Patrice Peean [France] ; Jean-Francois Demonet [France] ; Cyril Pernet [France] ; Dominique Cardebat [France] | Verb and noun generation tasks in Huntington's disease |
| 002070 |
Adrian P. Fawcett [Canada] ; Ilena Moro [Canada] ; Anthony E. Lang [Canada] ; Andres M. Lozano [Canada] ; William D. Hutchison [Canada] | Pallidal deep brain stimulation influences both reflexive and voluntary saccades in Huntington's disease |
| 002075 |
Jeroen P. P. Van Vugt [Pays-Bas] ; Karlijne K. E. Piet [Pays-Bas] ; Liesbeth J. Vink [Pays-Bas] ; Sabine Siesling [Pays-Bas] ; Aeilko H. Zwinderman [Pays-Bas] ; Huub A. M. Middelkoop [Pays-Bas] ; Raymund A. C. Roos [Pays-Bas] | Objective assessment of motor slowness in Huntington's disease: Clinical correlates and 2-year follow-up |
| 002101 |
Madhavi Thomas [États-Unis] ; Tetsuo Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis] | Minocycline in Huntington's disease: A pilot study |
| 002105 |
Shih-Ching Wang [Taïwan] ; Guey-Jen Lee-Chen [Taïwan] ; Cheng-Kung Wang [Taïwan] ; Chiung-Mei Chen [Taïwan] ; Lok-Ming Tang [Taïwan] ; Yih-Ru Wu [Taïwan] | Markedly asymmetrical parkinsonism as a leading feature of adult-onset Huntington's disease |
| 002123 |
Penelope Hogarth [États-Unis] ; Elise Kayson [États-Unis] ; Karl Kieburtz [États-Unis] ; Karen Marder [États-Unis] ; David Oakes [États-Unis] ; Diana Rosas [États-Unis] ; Ira Shoulson [États-Unis] ; Nancy S. Wexler [États-Unis] ; Anne B. Young [États-Unis] ; HONGWEI ZHAO [États-Unis] | Interrater agreement in the assessment of motor manifestations of Huntington's disease |
| 002133 |
Joanne Fielding [Australie] ; Nellie Georgiou-Karistianis [Australie] ; John Bradshaw [Australie] ; Lynette Millist [Australie] ; Andrew Churchyard [Australie] ; Edmond Chiu [Australie] ; Owen White [Australie] | Impaired modulation of the vestibulo-ocular reflex in Huntington's disease |
| 002138 |
Jürgen Andrich [Allemagne] ; Carsten Saft [Allemagne] ; Anneliese Arz [Allemagne] ; Birgit Schneider [Allemagne] ; Markus W. Agelink [Allemagne] ; Peter H. Kraus [Allemagne] ; Wilfried Kuhn [Allemagne] ; Thomas Müller [Allemagne] | Hyperhomocysteinaemia in treated patients with Huntington's disease |
| 002141 |
Aileen K. Ho [Royaume-Uni, Australie] ; Anna O. G. Robbins [Royaume-Uni] ; Stephen J. Walters [Royaume-Uni] ; Stephen Kaptoge [Royaume-Uni] ; Barbara J. Sahakian [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] | Health-related quality of life in Huntington's disease: A comparison of two generic instruments, SF-36 and SIP |
| 002164 |
Marina De Tommaso [Italie] ; Nicola Specchio [Italie] ; Vittorio Sciruicchio [Italie] ; Olimpia Difruscolo [Italie] ; Luigi Maria Specchio [Italie] | Effects of rivastigmine on motor and cognitive impairment in Huntington's disease |
| 002277 |
Brian F. O'Donnell [États-Unis] ; Marcia A. Wilt [États-Unis] ; Ann Marie Hake [États-Unis] ; Julie C. Stout [États-Unis] ; Sandra C. Kirkwood [États-Unis] ; Tatiana Foroud [États-Unis] | Visual function in Huntington's disease patients and presymptomatic gene carriers |
| 002294 |
Ruth H. Walker [États-Unis] ; Paul F. Good [États-Unis] ; P. Shashidharan [États-Unis] | TorsinA immunoreactivity in inclusion bodies in trinucleotide repeat diseases |
| 002324 |
Giovanni Abbruzzese [Italie] ; Alfredo Berardelli [Italie] | Sensorimotor integration in movement disorders |
| 002369 |
Ruth H. Walker [États-Unis] ; Joseph Jankovic [États-Unis] ; Elizabeth O'Hearn [États-Unis] ; Russell L. Margolis [États-Unis] | Phenotypic features of Huntington's disease-like 2 |
| 002389 |
Christopher Hawkes [Royaume-Uni] | Olfaction in neurodegenerative disorder |
| 002404 |
Thomas Gasser [Allemagne] ; Susan Bressman [États-Unis] ; Alexandra Dürr [France] ; Joseph Higgins [États-Unis] ; Thomas Klockgether [Allemagne] ; Richard H. Myers [États-Unis] | Molecular diagnosis of inherited movement disorders. Movement disorders Society Task Force on Molecular Diagnosis |
| 002445 |
Stefan Evers [Allemagne] ; Florian Stögbauer [Allemagne] | Genetic association of Huntington's disease and restless legs syndrome? A family report |
| 002495 |
Daphna Joel [Israël] ; Liat Ayalon [Israël] ; Ricardo Tarrasch [Israël] ; Ina Weinei [Israël] | Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease |
| 002614 |
Eric K. Richfield [États-Unis] ; Jean-Paul Vonsattel [États-Unis] ; Marcy E. Macdonald [États-Unis] ; ZHIQIANG SUN [États-Unis] ; Yun-Ping P. Deng [États-Unis] ; Anton Reiner [États-Unis] | Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease |
| 002621 |
Johannes Schiefer [Allemagne] ; G. Bernhard Landwehrmeyer [Allemagne] ; Hans-Gerd Lüesse [Allemagne] ; Arne Sprünken [Allemagne] ; Christiane Puls [Allemagne] ; Anna Milkereit [Allemagne] ; Eva Milkereit [Allemagne] ; Christoph M. Kosinski [Allemagne] | Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease |
| 002757 |
Anne-Catherine Bachoud-Levi [France] ; Philippe Hantraye [France] ; Marc Peschanski [France] | Fetal neural grafts for Huntington's disease: A prospective view |
| 002781 |
Katherine A. Johnson [Australie] ; Ross Cunnington [Australie, Royaume-Uni] ; John L. Bradshaw [Australie] ; Edmond Chiu [Australie] ; Robert Iansek [Australie] | Effect of an attentional strategy on movement-related potentials recorded from subjects with Huntington's disease |
| 002830 |
Jean-Pascal Lefaucheur [France] ; Anne-Catherine Bachoud-Levi [France] ; Catherine Bourdet [France] ; Thierry Grandmougin [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Jean-Denis Degos [France] ; Marc Peschanski [France] ; Fabrice Lisovoski [France] | Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease |
| 002907 |
Douglas J. Lanska [États-Unis] ; Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] | Seminal figures in the history of movement disorders: Hammond, Osler, and Huntington. Part 11 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000 |
| 002920 |
J. P. P. Van Vugt [Pays-Bas] ; S. Siesling [Pays-Bas] ; K. K. E. Piet [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; H. A. M. Middelkoop [Pays-Bas] ; J. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease |
| 002941 |
D. Joel [Israël] | Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease |
| 002948 |
Jaime Kulisevsky [Espagne] ; Irene Litvan [États-Unis] ; Marcelo L. Berthier [Espagne] ; Berta Pascual-Sedano [Espagne] ; Jane S. Paulsen [États-Unis] ; Jeffrey L. Cummings [États-Unis] | Neuropsychiatric assessment of Gilles de la Tourette patients: Comparative study with other hyperkinetic and hypokinetic movement disorders |
| 002950 |
Georg Becker [Allemagne] ; Daniela Berg [Allemagne] | Neuroimaging in basal ganglia disorders : Perspectives for Transcranial ultrasound |
| 002951 |
Saeed Bohlega [Arabie saoudite] ; Abdulrahman Al-Tahan [Arabie saoudite] ; Marios Kambouris [Arabie saoudite] ; Madai Divakaran [Arabie saoudite] | Neurodegenerative huntington-like disorder |
| 002974 |
Jorg Müller [Autriche] ; Gregor K. Wenning [Autriche] ; Jorg Wissel [Autriche] ; Werner Poewe [Autriche] | Intrafamilial heterogeneity of facial hyperkinesias : Chance association of tics, cranial dystonia, and huntington's disease? |
| 002979 |
D. I. Helder [Pays-Bas] ; A. A. Kaptein [Pays-Bas] ; G. M. J. Van Kempen [Pays-Bas] ; J. C. Van Houwelingen [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | Impact of Huntington's Disease on quality of life |
| 002987 |
Christopher G. Goetz [États-Unis] ; Teresa A. Chmura [États-Unis] ; Douglas J. Lanska [États-Unis] | History of chorea : Part 3 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June 2000 |
| 002A62 |
L. Quinn [États-Unis] ; R. Reilmann [États-Unis] ; K. Marder [États-Unis] ; A. M. Gordon [États-Unis] | Altered movement trajectories and force control during object transport in Huntington's Disease |
| 002B15 |
Alberto Priori [Italie] ; Luigi Polidori [Italie] ; Sabine Rona [Italie] ; Mario Manfredi [Italie] ; Alfredo Berardelli [Italie] | Spinal and cortical inhibition in Huntington's chorea |
| 002B27 |
E. H. Aylward [États-Unis] ; A.-M. Codori [États-Unis] ; A. Rosenblatt [États-Unis] ; M. Sherr [États-Unis] ; J. Brandt [États-Unis] ; O. C. Stine [États-Unis] ; P. E. Barta [États-Unis] ; G. D. Pearlson [États-Unis] ; C. A. Ross [États-Unis] | Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease |
| 002B88 |
Esther Cubo [États-Unis] ; Kathleen M. Shannon [États-Unis] ; Richard D. Penn [États-Unis] ; Jeffrey S. Kroin [États-Unis] | Internal globus pallidotomy in dystonia secondary to Huntington's disease |
| 002C09 |
Rebecca J. Carter [Royaume-Uni] ; Mark J. Hunt [Royaume-Uni] ; A. Jennifer Morton [Royaume-Uni] | Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene |
| 002C17 |
H. H. Fernandez [États-Unis] ; J. H. Friedman ; J. Grace [États-Unis] ; S. Beason-Hazen [États-Unis] | Donepezil for Huntington's disease |
| 002C44 |
E.-K. Tan [États-Unis] ; Joseph Jankovic [États-Unis] ; W. Ondo [États-Unis] | Bruxism in Huntington's disease |
| 002C90 |
M. H. Thaut [États-Unis] ; R. Miltner [Allemagne] ; H. W. Lange [Allemagne] ; C. P. Hurt [États-Unis] ; V. Hoemberg [Allemagne] | Velocity modulation and rhythmic synchronization of gait in Huntington's disease |
| 002D29 |
H. D. Rosas [États-Unis] ; W. J. Koroshetz [États-Unis] ; B. G. Jenkins [États-Unis] ; Y. I. Chen [États-Unis] ; D. L. Hayden [États-Unis] ; M. F. Beal [États-Unis] ; M. E. Cudkowicz [États-Unis] | Riluzole therapy in Huntington's Disease (HD) |
| 002D53 |
A. Berardelli [Italie] ; J. Noth [Allemagne] ; P. D. Thompson [Australie] ; E. L. E. M. Bollen [Pays-Bas] ; A. Curra [Italie] ; G. Deuschl [Allemagne] ; J. G. Van Dijk [Pays-Bas] ; R. Töpper [Allemagne] ; T. Schwarz [Allemagne] ; R. A. C. Roos [Pays-Bas] | Pathophysiology of chorea and bradykinesia in Huntington's disease |
| 002D76 |
K. R. Müller-Vahl [Allemagne] ; U. Schneider [Allemagne] ; H. M. Emrich [Allemagne] | Nabilone increases choreatic movements in Huntington's disease |
| 002E28 |
E. D. Louis [États-Unis] ; P. Lee [États-Unis] ; L. Quinn [États-Unis] ; K. Marder [États-Unis] | Dystonia in Huntington's disease : Prevalence and clinical characteristics |
| 002E38 |
N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; E. Chiu [Australie] ; A. Tudor [Australie] ; L. O'Gorman [Australie] ; J. G. Phillips [Australie] | Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease |
| 002E52 |
O. Lindvall [Suède] | Cerebral implantation in movement disorders : State of the art |
| 002E64 |
E. D. Louis [États-Unis] ; K. Marder [États-Unis] ; C. Moskowitz [États-Unis] ; P. Greene [États-Unis] | Arm elevation in Huntington's disease : Dystonia or levitation? |
| 002E77 |
J. I. Hoff [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | A review of the assessment of dyskinesias |
| 002E88 |
S. Frucht [États-Unis] ; S. Fahn [États-Unis] ; K. M. Shannon [États-Unis] ; C. H. Waters [États-Unis] | A 32-year-old man with progressive spasticity and parkinsonism |
| 002F00 |
S. Siesling [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. A. H. Zwinderman [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas] | Unified Huntington's disease rating scale : A follow up |
| 002F18 |
G. De Boo [Pays-Bas] ; A. Tibben [Pays-Bas] ; J. Hermans [Pays-Bas] ; A. Maat [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | Subtle involuntary movements are not reliable indicators of incipient Huntington's disease |
| 002F31 |
M. T. M. Hu [Royaume-Uni] ; K. Ray Chaudhuri [Royaume-Uni] | Repetitive belching, aerophagia, and torticollis in Huntington's disease : A case report |
| 002F70 |
R. Töpper [Allemagne] ; M. Schwarz [Allemagne] ; H. W. Lange [Allemagne] ; H. Hefter [Allemagne] ; J. Noth [Allemagne] | Neurophysiological abnormalities in the Westphal variant of Huntington's disease |
| 003001 |
E. Silber [Afrique du Sud] ; J. Kromberg [Afrique du Sud] ; J. A. Temlett [Afrique du Sud] ; A. Krause [Afrique du Sud] ; D. Saffer [Afrique du Sud] | Huntington's disease confirmed by genetic testing in five African families |
| 003008 |
J. M. Hausdorff [États-Unis] ; M. E. Cudkowicz [États-Unis] ; R. Firtion [États-Unis] ; J. Y. Wei [États-Unis] ; A. L. Goldberger [États-Unis] | Gait variability and basal ganglia disorders : Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease |
| 003104 |
| |
| 003105 |
| |
| 003159 |
A. Straube [Allemagne] ; J.-B. Mennicken [Allemagne] ; M. Riedel [Allemagne] ; T. Eggert [Allemagne] ; N. Müller [Allemagne] | Saccades in Gilles de la Tourette's syndrome |
| 003208 |
H. Ackermann [Allemagne] ; I. Hertrich [Allemagne] ; I. Daum [Allemagne] ; G. Scharf [Allemagne] ; S. Spieker [Allemagne] | Kinematic analysis of articulatory movements in central motor disorders |
| 003215 |
N. Georgiou [Australie] ; J. G. Phillips [Australie] ; J. L. Bradshaw [Australie] ; R. Cunnington [Australie] ; E. Chiu [Australie] | Impairments of movement kinematics in patients with Huntington's disease : A comparison with and without a concurrent task |
| 003247 |
J. N. Caviness [États-Unis] ; M. Kurth [États-Unis] | Cortical myoclonus in Huntington's disease associated with an enlarged somatosensory evoked potential |
| 003289 |
S. Siesling [Pays-Bas] ; A. H. Zwinderman [Pays-Bas] ; J. P. P. Van Vugt [Pays-Bas] ; K. Kieburtz [États-Unis] ; R. A. C. Roos [Pays-Bas] | A shortened version of the motor section of the unified Huntington's disease rating scale |
| 003295 |
P. G. Como [États-Unis] ; A. J. Rubin [États-Unis] ; C. F. O'Brien [États-Unis] ; K. Lawler [États-Unis] ; C. Hickey [États-Unis] ; A. E. Rubin [États-Unis] ; R. Henderson [États-Unis] ; M. P. Mcdermott [États-Unis] ; T. Mcdermott [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis] | A controlled trial of fluoxetine in nondepressed patients with Huntington's disease |
| 003306 |
| Unified Huntington's Disease Rating Scale : Reliability and consistency |
| 003318 |
F. Cicchetti [Canada] ; A. Parent [Canada] | Striatal interneurons in Huntington's disease : Selective increase in the density of calretining-immunoreactive medium-sized neurons |
| 003332 |
S. D. Taylor-Robinson [Royaume-Uni] ; R. A. Weeks ; D. J. Bryant [Royaume-Uni] ; J. Sargentoni [Royaume-Uni] ; C. D. Marcus [Royaume-Uni] ; A. E. Harding ; D. J. Brooks | Proton magnetic resonance spectroscopy in Huntington's disease : Evidence in favour of the glutamate excitotoxic theory ? |
| 003361 |
J. P. P. Van Vugt [Pays-Bas] ; B. J. Van Hilten [Pays-Bas] ; R. A. C. Roos [Pays-Bas] | Hypokinesia in Huntington's disease |
| 003371 |
D. S. Sax [États-Unis] ; R. Powsner [États-Unis] ; A. Kim [États-Unis] ; S. Tilak [États-Unis] ; R. Bhatia [États-Unis] ; L. A. Cupples [États-Unis] ; R. H. Myers [États-Unis] | Evidence of cortical metabolic dysfunction in early Huntington's disease by single-photon-emission computed tomography |
| 003385 |
| Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD) |
| 003394 |
M. A. Nance [États-Unis] ; G. Sanders [États-Unis] | Characteristics of individuals with Huntington disease long-term care |
| 003395 |
T. Ashizawa [États-Unis] ; Joseph Jankovic [États-Unis] | Cervical dystonia as the initial presentation of Huntington's disease |
| 003411 |
A. Feigin [États-Unis] ; K. Kieburtz [États-Unis] ; P. Como [États-Unis] ; C. Hickey [États-Unis] ; K. Claude [États-Unis] ; D. Abwender [États-Unis] ; C. Zimmerman [États-Unis] ; K. Steinberg [États-Unis] ; I. Shoulson [États-Unis] | Assessment of coenzyme Q10 tolerability in Huntington's disease |
| 003423 |
K. Kieburtz [États-Unis] ; A. Feigin ; M. Mcdermott ; P. Como ; D. Abwender ; C. Zimmerman ; C. Hickey ; C. Orme ; K. Claude ; J. Sotack ; J. T. Greenamyre ; C. Dunn ; I. Shoulson | A controlled trial of remacemide hydrochloride in Huntington's disease |
| 003424 |
N. G. Ranen [États-Unis] ; C. E. Peyser [États-Unis] ; J. T. Coyle [États-Unis] ; F. W. Bylsma [États-Unis] ; M. Sherr [États-Unis] ; L. Day [États-Unis] ; M. F. Folstein [États-Unis] ; J. Brandt [États-Unis] ; C. A. Ross [États-Unis] ; S. E. Folstein [États-Unis] | A controlled trial of idebenone in Huntington's disease |
| 003431 |
Joseph Jankovic [États-Unis] ; T. Ashizawa | Tourettism associated with Huntington's disease |
| 003456 |
N. Georgiou [Australie] ; J. L. Bradshaw [Australie] ; J. G. Phillips [Australie] ; E. Chiu ; J. A. Bradshaw [Australie] | Reliance on advance information and movement sequencing in Huntington's disease |
| 003496 |
A. Feigin [États-Unis] ; K. Kieburtz ; K. Bordwell ; P. Como ; K. Steinberg ; J. Sotack ; C. Zimmerman ; C. Hickey ; C. Orme ; I. Shoulson | Functional decline in Huntington's disease |
| 003523 |
G. W. Rebok [États-Unis] ; F. W. Bylsma ; P. M. Keyl ; J. Brandt ; S. E. Folstein | Automobile driving in Huntington's disease |
| 003525 |
R. Sprengelmeyer [Allemagne] ; A. G. M. Canavan ; H. W. Lange ; V. Hömberg | Associative learning in degenerative neostriatal disorders : contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases |
| 003544 |
| |
| 003603 |
S. S. Rich [États-Unis] ; F. Ovsiew | Leuprolide acetate for exhibitionism in Huntington's disease |
| 003622 |
A. Priori [Italie] ; A. Berardelli ; M. Inghilleri ; L. Polidori ; M. Manfredi | Electromyographic silent period after transcranial brain stimulation in Huntington's disease |
| 003629 |
P. D. Thompson [Royaume-Uni] ; K. P. Bhatia [Royaume-Uni] ; P. Brown [Royaume-Uni] ; M. B. Davis [Royaume-Uni] ; M. Pires ; N. P. Quinn [Royaume-Uni] ; P. Luthert ; M. Honovar ; M. D. P'Brien ; C. D. Marsden [Royaume-Uni] ; A. E. Harding [Royaume-Uni] | Cortical myoclonus in Huntington's disease |
| 003634 |
J. G. Phillips [Australie] ; J. L. Bradshaw ; E. Chiu ; J. A. Bradshaw | Characteristics of handwriting of patients with Huntington's disease |
| 003651 |
| |
| 003740 |
T. Kuwert [Allemagne] ; J. Noth ; D. Scholz [Allemagne] ; M. Schwarz ; H. W. Lange ; R. Töpper ; H. Herzog [Allemagne] ; A. Aulich ; L. E. Feinendegen [Allemagne] | Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease |
| 003752 |
F. W. Bylsma [États-Unis] ; J. Rothlind ; M. R. Hall ; S. E. Folstein ; J. Brandt | Assessment of adaptive functioning in Huntington's disease |
| 003757 |
F. Carella [Italie] ; V. Scaioli ; C. Ciano ; S. Binelli ; D. Oliva [Italie] ; F. Girotti [Italie] | Adult onset myoclonic Huntington's disease |
| 003839 |
| |
| 003844 |
E. Mohr ; P. Browers ; J. J. Claus ; U. M. Mann ; P. Fedio ; T. N. Chase | Visuospatial cognition in Huntington's disease |
| 003946 |
J. B. Jr Penney ; A. B. Young ; I. Shoulson ; S. Starosta-Rubenstein ; S. R. Snodgrass ; J. Sanchez-Ramos ; M. Ramos-Arroyo ; F. Gomez ; G. Penchaszadeh ; J. Alvir ; J. Esteves ; I. Dequiroz ; N. Marsol ; H. Moreno ; P. M. Conneally ; E. Bonilla ; N. S. Wexler | Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals |
| 003963 |
V. Hoêmberg ; H. W. Lange | Central motor conduction to hand and leg muscles in Huntington's disease |
| 003974 |
J. H. Friedman ; M. Ambler | A case of senile chorea |
| 003A34 |
R. L. Albin ; A. B. Young | Somatosensory phenomena in Huntington's disease |
| 003A48 |
V. P. Misra ; M. Baraitser ; A. E. Harding | Genetic prediction in Huntington's disease: what are the limitations imposed by pedigree structure? |
| 003A56 |
R. Agostino ; A. Berardelli ; G. Cruccu ; G. Pauletti ; F. Stocchi ; M. Manfredi | Correlation between facial involuntary movements and abnormalities of blink and corneal reflexes in Huntington's chorea |
| 003A92 |
A. M. Bonnet ; G. Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire ; Y. De Smet ; Yves Agid [France] | Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea |
